New Zealand shares rose to a record close, led by a2 Milk Co as Australian investors continued to back growing demand for the milk marketer's infant formula, and as Ryman Healthcare extended its rally from upbeat earnings last week.
The S&P/NZX 50 Index rose 69.1 points, or 1.2 per cent, to 6077.62, outperforming other markets across Asia. Within the index, 41 stocks gained, four declined, and five were unchanged. Turnover was $170.2 million.
A2 Milk led the benchmark index high, jumping 11 per cent to a record close of $1.09. The milk marketer has soared 42 per cent since November 3 as investors grow increasingly bullish about the company's prospects selling infant formula, and has attracted new investors after upgrading earnings guidance last week and with the exit of cornerstone investor Freedom Foods.
"Just last week a number of research analysts bumped up their price targets to between $1 and $1.23, so investors are starting to get pretty bullish on a2," said Grant Williamson, a director at Hamilton Hindin Greene.
Ryman Healthcare rose 3.3 per cent to $7.90, adding to Friday's 2.6 per cent gain after the country's biggest retirement village operator posted a 23 per cent increase in first-half profit.